Before pregnancy may matter most

The news here is not a treatment, or a warning dressed up as certainty. It is a large observational signal: preliminary research presented at the American Heart Association’s Scientific Sessions 2026 found that women with chronic hypertension had a 30% higher risk of having a baby with critical congenital heart disease than women whose blood pressure was normal before and during pregnancy.

Critical congenital heart disease is the severe end of congenital heart defects. Babies born with it often need surgery or catheter procedures within the first year of life, then long cardiac follow-up after that. When a study connects that kind of condition to something as common as blood pressure, the human stakes are immediate. Blood pressure is measurable. Heart development in a fetus is not something a parent can watch happening.

According to Medical Xpress, the research looked at hypertension-related disorders in pregnancy and their association with critical congenital heart disease in the U.S. The study period ran from 2018 to 2024. That makes this an observational analysis, not a trial, which matters: it can identify links, but it cannot prove that high blood pressure caused the heart defects.

Even so, the pattern the researchers describe is not trivial. Maternal hypertension became markedly more common over the study period, rising from about 9.4% of pregnancies in 2018 to 13.9% in 2024, according to the presentation. Over a similar stretch, the prevalence of critical congenital heart disease rose from 5.8 cases per 10,000 births to 6.4 per 10,000 births in 2023–2024, or nearly 4,000 infants in the U.S. each year.

The distinction inside the findings is also the most interesting one. The stronger association was with chronic hypertension — high blood pressure that existed before pregnancy or was diagnosed before 20 weeks — rather than with gestational hypertension that develops later. That does not settle the biology, and the researchers themselves say future work needs to examine timing, severity and treatment. But it shifts the center of the story slightly backward, to health before pregnancy begins.

That is a difficult place in medicine and policy, because “before pregnancy” is not a neat clinical moment. It is ordinary life, often without specialist care, sometimes without any care at all. A result like this does not tell an individual patient what will happen, and it should not be read as a sentence on anyone’s pregnancy. The absolute risk of critical congenital heart disease remains low, as pediatric cardiologist Flora Nuñez Gallegos said in comments carried by Medical Xpress. But low absolute risk is not the same as no public-health importance, especially when the exposure is becoming more common.

There is another reason to be careful. This was conference research, not a published peer-reviewed paper, and the excerpt does not provide the full methods, sample size or how the analysis accounted for confounding factors such as diabetes, medication use or access to prenatal care. Those are not technical footnotes. They affect how much weight the 30% figure can bear.

What the study can support, for now, is narrower and still useful: maternal cardiovascular health appears to be tied to fetal heart development in ways medicine is still mapping, and chronic hypertension looks more consequential than a blood-pressure problem that starts later in pregnancy. For families, that is not an abstract epidemiologic point. It is a reminder that some of the conditions shaping a baby’s first year may begin long before the anatomy scan.